Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Joel Klein is Director at BXP, Inc.. OQRO lists 5 transactions filed with the SEC under this name, the latest on Oct 1, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
1
BXP, Inc.BXP
5 disclosures · Jan 2026 – Oct 2026
Sep 30, 2026552.28disclosed Oct 1
DetailsOfficial recordJun 30, 2026496.41disclosed Jul 1
DetailsOfficial recordMay 29, 20263,332disclosed Jun 2
DetailsOfficial recordMar 31, 2026650.29disclosed Apr 1
DetailsOfficial recordDec 31, 2025500.15disclosed Jan 6
DetailsOfficial recordJoel Klein has no open-market purchase on record since 2015 across 2 companies. Sales in 3 of the 12 years since 2015.
In SEC filings since 2015: no open-market purchase is on record; the latest open-market sale is from 2021.
2 companies: Oscar Health (OSCR, 2021), BXP, Inc. (BXP, 2015–2016).
Joel Klein has no open-market purchase on record since 2015 across 2 companies. Sales in 3 of the 12 years since 2015.
Joel Klein reported 0 open-market purchases and 3 sales since 2015; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2021 | — | $2.95M1×1 trade |
| 2016 | — | $115K1×1 trade |
| 2015 | — | $54K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Joel Klein reported 0 open-market purchases and 2 sales here, 2015 to 2016.
Joel Klein reported 0 open-market purchases and 1 sale here, 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.